Vertical 01 · Pharmaceuticals

Pharmaceutical-grade chitosan for the next generation of therapeutics.

USP-aligned, endotoxin-controlled, and shipped with a complete provenance dossier — chitosan you can build a clinical program on.

Pharmaceutical laboratory with blue-lit petri dish and cleanroom equipment
GMP
Manufacturing grade
85% - 95%+
Deacetylation
<0.5
EU/mg endotoxins
50–500
kDa Mw range

Why chitosan, for this industry.

Chitosan's mucoadhesive, hemostatic, and biocompatible properties make it uniquely suited to modern pharmaceutical development. Our pharma-grade material is produced under GMP conditions with tight molecular-weight control and endotoxin limits appropriate for parenteral and topical applications.

Largest & most differentiated market

Advanced wound care — hemostasis and healing in one material.

Chitosan accelerates hemostasis naturally and supports faster re-epithelialization across surgical, trauma, and chronic wound settings.

  • Rapid intrinsic hemostasis independent of clotting factors
  • Antimicrobial film and dressing formats for surgical and trauma use
  • Accelerates closure and re-epithelialization in chronic wound care
  • Compatible with antimicrobials, growth factors, and cell-based therapies
Sterile white chitosan fiber wound dressing on a clinical blue background
Applications · therapeutic matrix

Chitosan's diversity disrupting wound care.

5 programs
P01
Program

Advanced wound care

Hemostatic dressings and antimicrobial films for surgical and trauma applications. Naturally accelerates hemostasis without synthetic additives.

P02
Program

Anti-inflammatory & regenerative therapies

Low-molecular-weight chitosan modulates cytokine signaling to shift tissue from inflammation to repair.

P03
Program

Controlled drug delivery

pH-responsive matrix carriers for oral, nasal, and transdermal delivery — particularly effective for peptide and small-molecule payloads.

P04
Program

Tissue engineering scaffolds

Porous 3D scaffolds for cartilage, bone, and skin regeneration — biocompatible, biodegradable, and tunable in porosity.

P05
Program

Ophthalmic formulations

Mucoadhesive eye drops and gel systems with extended retention time on the ocular surface.

Grade specification
Grade
GMP
Deacetylation
85% - 95%+
Mw range
50–500 kDa
Endotoxins
<0.5 EU/mg

Available in bulk and R&D quantities. Full regulatory support package including DMF-ready documentation, elemental impurity data, and residual solvent testing.